Irene Schiattino

Tumour necrosis factor (TNF)α −308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis

M Cuchacovich, Lilian Soto, M Edwardes et al. · Scandinavian Journal of Rheumatology · 2006 · 74 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Tumour necrosis factor‐α (TNF‐α) levels and influence of −308 TNF‐α promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis

M Cuchacovich, Lorena Ferreira, Marta Aliste et al. · Scandinavian Journal of Rheumatology · 2004 · 73 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Impact of large industrial emission sources on mortality and morbidity in Chile: A small-areas study

Pablo Ruiz-Rudolph, Nelson Enrique Arias-Ortiz, Sandra Pardo et al. · Environment International · 2016 · 47 citations · Full text

Public Health, Environmental Sciences, Air Pollution +13

Ex vivo lipopolysaccharide (LPS)-induced TNF-alpha, IL-1beta, IL-6 and PGE2 secretion in whole blood from Type 1 diabetes mellitus patients with or without aggressive periodontitis.

A. Verónica Araya, Violeta Pavez, Claudio Pérez et al. · PubMed · 2004 · 35 citations

Dentistry, Periodontics, Periodontology +17

The -308 polymorphism in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene and ex vivo lipopolysaccharide-induced TNF-alpha expression in patients with aggressive periodontitis and/or type 1 diabetes mellitus.

Claudio Pérez, Fermín E. González, Violeta Pavez et al. · PubMed · 2005 · 34 citations

Life Sciences, Immunology, Molecular Genetics +14